These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30304748)

  • 1. [Neuroendocrine Neoplasia within the German NET Registry].
    ; ;
    Z Gastroenterol; 2018 Oct; 56(10):1237-1246. PubMed ID: 30304748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
    Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
    Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroendocrine tumours of the GI tract--data from the German NET Registry].
    Begum N; Maasberg S; Plöckinger U; Anlauf M; Rinke A; Pöpperl G; Lehnert H; Izbicki JR; Krausch M; Vashist YK; Raffel A; Bürk CG; Hoffmann J; Goretzki P; Pape UF;
    Zentralbl Chir; 2014 Jun; 139(3):276-83. PubMed ID: 23042103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry.
    Kollar A; Bütikofer L; Ochsenbein A; Stettler C; Trepp R
    Swiss Med Wkly; 2020 Jan; 150():w20176. PubMed ID: 31940430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms.
    Borbath I; Garcia-Carbonero R; Bikmukhametov D; Jimenez-Fonseca P; Castaño A; Barkmanova J; Sedlackova E; Kollár A; Christ E; Kaltsas G; Kos-Kudla B; Maasberg S; Verslype C; Pape UF
    Eur J Cancer; 2022 Jun; 168():80-90. PubMed ID: 35472579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric neuroendocrine neoplasias: manifestations and comparative outcomes.
    Felder S; Jann H; Arsenic R; Denecke T; Prasad V; Knappe-Drzikova B; Maasberg S; Wiedenmann B; Pavel M; Pascher A; Pape UF
    Endocr Relat Cancer; 2019 Sep; 26(9):751-763. PubMed ID: 31272081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
    Anlauf M
    Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
    Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
    Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastroenteropancreatic neuroendocrine tumors].
    Rayes N; Denecke T
    Radiologe; 2021 Dec; 61(12):1129-1138. PubMed ID: 34727206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
    Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.
    Neychev V; Kebebew E
    Int J Surg Oncol; 2017; 2017():6424812. PubMed ID: 28593056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site.
    Pavel M; O'Toole D; Costa F; Capdevila J; Gross D; Kianmanesh R; Krenning E; Knigge U; Salazar R; Pape UF; Öberg K;
    Neuroendocrinology; 2016; 103(2):172-85. PubMed ID: 26731013
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease.
    Matrood S; Apostolidis L; Schrader J; Krug S; Lahner H; Ramaswamy A; Librizzi D; Kender Z; Kröcher A; Kreutzfeldt S; Gress TM; Rinke A
    Front Endocrinol (Lausanne); 2021; 12():709256. PubMed ID: 34690926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.
    Singh S; Dey C; Kennecke H; Kocha W; Maroun J; Metrakos P; Mukhtar T; Pasieka J; Rayson D; Rowsell C; Sideris L; Wong R; Law C
    Ann Surg Oncol; 2015 Aug; 22(8):2685-99. PubMed ID: 25366583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany.
    Scherübl H; Streller B; Stabenow R; Herbst H; Höpfner M; Schwertner C; Steinberg J; Eick J; Ring W; Tiwari K; Zappe SM
    World J Gastroenterol; 2013 Dec; 19(47):9012-9. PubMed ID: 24379626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide Receptor Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors - from oncology perspective.
    Kolasińska-Ćwikła A; Łowczak A; Maciejkiewicz KM; Ćwikła JB
    Nucl Med Rev Cent East Eur; 2018; 21(2):. PubMed ID: 29741203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.
    Hauck L; Bitzer M; Malek N; Plentz RR
    Scand J Gastroenterol; 2016 Jan; 51(1):55-9. PubMed ID: 26137871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.